Literature DB >> 17170438

Improved growth of enteric adenovirus type 40 in a modified cell line that can no longer respond to interferon stimulation.

Victoria Sherwood1, Hans-Gerhard Burgert, Yun-Hsiang Chen, Sandeep Sanghera, Socrates Katafigiotis, Richard E Randall, Ian Connerton, Kenneth H Mellits.   

Abstract

Human enteric adenoviruses propagate poorly in conventional human cell lines used to grow other adenovirus serotypes. As human enteric adenoviruses have a defect in counteracting the cellular interferon (IFN) response in cell culture, to aid in growth of the virus, a 293-based cell line defective in its ability to respond to IFN was constructed. This cell line (293-SV5/V) constitutively expresses V-protein of the paramyxovirus Simian virus 5, which degrades the signal transducer and activator of transcription 1 (STAT1) and thereby prevents the STAT1-mediated IFN response. Analysis of human enteric adenovirus type 40 (HAdV-40)-infected 293-SV5/V cells compared with parental 293 cells shows that the recombinant line allows more rapid production of virus and results in higher titres. These results suggest that the defect in HAdV-40 in counteracting the IFN response can be overcome at least partially through the use of 293-SV5/V cell lines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17170438     DOI: 10.1099/vir.0.82445-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Adenovirus Infection of Human Enteroids Reveals Interferon Sensitivity and Preferential Infection of Goblet Cells.

Authors:  Mayumi K Holly; Jason G Smith
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

2.  Enhancement of enteric adenovirus cultivation by viral transactivator proteins.

Authors:  Misoon Kim; Mi Young Lim; GwangPyo Ko
Journal:  Appl Environ Microbiol       Date:  2010-02-05       Impact factor: 4.792

3.  Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization.

Authors:  Jason G Smith; Mariena Silvestry; Steffen Lindert; Wuyuan Lu; Glen R Nemerow; Phoebe L Stewart
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

4.  A One Year Study on the Concentrations of Norovirus and Enteric Adenoviruses in Wastewater and A Surface Drinking Water Source in Norway.

Authors:  Ricardo C Grøndahl-Rosado; Ekaterina Yarovitsyna; Elin Trettenes; Mette Myrmel; Lucy J Robertson
Journal:  Food Environ Virol       Date:  2014-08-03       Impact factor: 2.778

5.  Elution Is a Critical Step for Recovering Human Adenovirus 40 from Tap Water and Surface Water by Cross-Flow Ultrafiltration.

Authors:  Hang Shi; Irene Xagoraraki; Kristin N Parent; Merlin L Bruening; Volodymyr V Tarabara
Journal:  Appl Environ Microbiol       Date:  2016-07-29       Impact factor: 4.792

Review 6.  Distinct Effects of Type I and III Interferons on Enteric Viruses.

Authors:  Harshad Ingle; Stefan T Peterson; Megan T Baldridge
Journal:  Viruses       Date:  2018-01-20       Impact factor: 5.048

7.  Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.

Authors:  Martin Pacesa; Rodinde Hendrickx; Manuela Bieri; Justin W Flatt; Urs F Greber; Silvio Hemmi
Journal:  Virol J       Date:  2017-08-18       Impact factor: 4.099

8.  Efficient amplification of chimeric adenovirus 5/40S vectors carrying the short fiber protein of Ad40 in suspension cell cultures.

Authors:  Marta Miralles; María Mercedes Segura; Meritxell Puig; Assumpció Bosch; Miguel Chillon
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

9.  High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7.

Authors:  Itsuki Hamamoto; Hiroshi Takaku; Masato Tashiro; Norio Yamamoto
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Porcine sapovirus replication is restricted by the type I interferon response in cell culture.

Authors:  Myra Hosmillo; Frédéric Sorgeloos; Rintaro Hiraide; Jia Lu; Ian Goodfellow; Kyoung-Oh Cho
Journal:  J Gen Virol       Date:  2014-10-10       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.